| # | Title | Journal | Year | Citations |
|---|
| 1 | Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies | Lancet Neurology, The | 2019 | 1,414 |
| 2 | Genome-wide association study identifies 30 loci associated with bipolar disorder | Nature Genetics | 2019 | 1,191 |
| 3 | Sex and gender issues in multiple sclerosis | Therapeutic Advances in Neurological Disorders | 2013 | 368 |
| 4 | Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial | Lancet Neurology, The | 2012 | 329 |
| 5 | Class II HLA interactions modulate genetic risk for multiple sclerosis | Nature Genetics | 2015 | 312 |
| 6 | Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial | Lancet Neurology, The | 2017 | 305 |
| 7 | Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms | Movement Disorders | 2019 | 258 |
| 8 | Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene | American Journal of Human Genetics | 2010 | 210 |
| 9 | The Impact of Body Mass Index on the Prevalence of Low Back Pain | Spine | 2010 | 173 |
| 10 | Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in theTITF1/NKX2-1gene | Journal of Neurology, Neurosurgery and Psychiatry | 2012 | 172 |
| 11 | Body Mass Index as a Risk Factor for Developing Chronic Low Back Pain | Spine | 2013 | 166 |
| 12 | The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease | Alzheimer's and Dementia | 2015 | 152 |
| 13 | Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia | Brain | 2020 | 149 |
| 14 | High spontaneous activity of C-nociceptors in painful polyneuropathy | Pain | 2012 | 148 |
| 15 | DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis | Nature Communications | 2018 | 147 |
| 16 | Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study | Brain | 2010 | 132 |
| 17 | Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts | Movement Disorders | 2019 | 122 |
| 18 | Interactions between antiepileptic drugs and hormones | Seizure: the Journal of the British Epilepsy Association | 2015 | 121 |
| 19 | Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018 | European Stroke Journal | 2019 | 116 |
| 20 | Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population | PLoS ONE | 2012 | 105 |
| 21 | Surgical Site Infections after Deep Brain Stimulation Surgery: Frequency, Characteristics and Management in a 10-Year Period | PLoS ONE | 2014 | 102 |
| 22 | Diffusion Tensor Imaging Surpasses Cerebrospinal Fluid as Predictor of Cognitive Decline and Medial Temporal Lobe Atrophy in Subjective Cognitive Impairment and Mild Cognitive Impairment | Journal of Alzheimer's Disease | 2013 | 95 |
| 23 | Loss of Perivascular Kir4.1 Potassium Channels in the Sclerotic Hippocampus of Patients With Mesial Temporal Lobe Epilepsy | Journal of Neuropathology and Experimental Neurology | 2012 | 92 |
| 24 | Parkinson's disease correlates with promoter methylation in the α‐synuclein gene | Movement Disorders | 2015 | 92 |
| 25 | Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting | PLoS ONE | 2013 | 91 |
| 26 | Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease | Neurobiology of Aging | 2013 | 90 |
| 27 | Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia | JAMA Neurology | 2021 | 89 |
| 28 | Genome-Wide DNA Methylation Profiles Indicate CD8+ T Cell Hypermethylation in Multiple Sclerosis | PLoS ONE | 2015 | 88 |
| 29 | Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial | Lancet Neurology, The | 2022 | 88 |
| 30 | Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy | Brain | 2014 | 86 |
| 31 | European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre‐hospital management of stroke | European Journal of Neurology | 2018 | 83 |
| 32 | European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage | European Stroke Journal | 2021 | 83 |
| 33 | Cluster Headache. The Sweating Pattern During Spontaneous Attacks | Cephalalgia | 1981 | 82 |
| 34 | Headache, migraine and cardiovascular risk factors: The HUNT study | European Journal of Neurology | 2011 | 82 |
| 35 | COVID-19 and cerebrovascular diseases: a comprehensive overview | Therapeutic Advances in Neurological Disorders | 2020 | 81 |
| 36 | White matter imaging changes in subjective and mild cognitive impairment | Alzheimer's and Dementia | 2012 | 80 |
| 37 | Interleukin 23 Levels Are Increased in Carotid Atherosclerosis | Stroke | 2015 | 79 |
| 38 | The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell–derived sensory neurons of erythromelalgia patients | Pain | 2019 | 74 |
| 39 | Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients | Multiple Sclerosis Journal | 2009 | 73 |
| 40 | An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts | Health and Quality of Life Outcomes | 2015 | 73 |
| 41 | Association of Blood Pressure With Outcomes in Acute Stroke Thrombectomy | Hypertension | 2020 | 72 |
| 42 | Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial | Lancet Neurology, The | 2010 | 70 |
| 43 | Cross-Sectional and Longitudinal MRI Brain Scans Reveal Accelerated Brain Aging in Multiple Sclerosis | Frontiers in Neurology | 2019 | 69 |
| 44 | The impact of seizures on pregnancy and delivery | Seizure: the Journal of the British Epilepsy Association | 2015 | 68 |
| 45 | Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease | Acta Neuropathologica | 2020 | 68 |
| 46 | Bone loss associated with use of antiepileptic drugs | Expert Opinion on Drug Safety | 2010 | 66 |
| 47 | Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease | JAMA Neurology | 2018 | 66 |
| 48 | Reducing door-to-needle times in stroke thrombolysis to 13 min through protocol revision and simulation training: a quality improvement project in a Norwegian stroke centre | BMJ Quality and Safety | 2019 | 66 |
| 49 | The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease | Movement Disorders | 2019 | 66 |
| 50 | Effect of modified Atkins diet in adults with drug‐resistant focal epilepsy: A randomized clinical trial | Epilepsia | 2018 | 65 |
